Rinsho Shinkeigaku (Clinical Neurology)

The 46th Annual Meeting of the Japanese Society of Neurology

Molecular and anatomical bases of dystonia: X-linked recessive dystonia-parkinsonism (DYT3)

Ryuji Kaji, M.D., Ph. D.1), Satoshi Goto, M.D.2), Gen Tamiya, M.D.1) and LV Lee, M.D.3)

1)Department of Clinical Neuroscience, Tokushima University
2)Department of Neurosurgery, Kumamoto University
3)Philippines National Children's Medical Center

Pathological findings in dystonia have been unclear. X-linked recessive dystonia-parkinsonism (XDP, DYT3), endemic in the Panay island, the Philippines, is characterized by the clinical onset with dystonia followed by parkinsonism. It provides a unique opportunity to explore the anatomical basis of dystonia, because it has discernible pathological changes even at its early phase of dystonia. After extensive searches for the anatomical basis in XDP, we found selective loss of striosomal neurons in the striatum in dystonic patients'brain. Because striosomal neurons inhibit nigrostriatal dopaminergic neurons via GABAergic innervation, the striosomal lesion could account for dopamine excess in the striatum, which in turn causes a hyperkinetic state or dystonia. We also identified the causative gene as one of the general transcription factor genes, TAF1. This abnormality markedly reduced the expression of dopamine D2 receptor gene (DRD2) in neurons. XDP has certain similarities to Huntington disease not only in pathological and clinical findings, but also the molecular mechanism, which disturbs expression of genes essential for striatal neurons, such as DRD2. Therapeutic intervention may become possible through pharmacological measures that affect gene expression.

(CLINICA NEUROL, 45: 811－814, 2005)
key words: dystonia, DYT3, striosome, dopamine, TAF1

(Received: 25-May-05)